#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma Sickle cell anaemia Pulmonary hypertension Osteopetrosis HER2 mutant non-small cell lung cancer Mantle cell lymphoma stage III Henoch-Schonlein purpura Alexander disease Epilepsy Monogenic diabetes IgA nephropathy Ocular myasthenia Dementia with Lewy bodies Aplastic anaemia Asthma More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Trials in Disease Prolymphocytic leukaemia – Life with Disease Mucopolysaccharidosis Osteosarcoma metastatic Synovial sarcoma metastatic – Treatment Lymphangioma – Treatment Rosai-Dorfman syndrome – Diagnostics Inclusion body myositis – Life with Disease Wolfram syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ramucirumab Fentanyl Landiolol Hydrochloride Casimersen GSKVX000000044501 Oxcarbazepine For-6219 BROLUCIZUMAB Tepotinib Sodium Iodide (123 I) Remifentanil Hydrochloride Soya Oil, Purified Vincristine Hydroxi-Methionine Calcium LUNRESERTIB Specific Nucleic Acid Sna-Her2 Melphalan Hydrochloride Rbl016.2 Temozolomide Lymecycline More therapies…

    Learn about Your Condition

    Adenocarcinoma Incisional hernia Dystonic tremor Spinal osteoarthritis Respiratory tract infection Restless legs syndrome Hodgkin's disease recurrent Nodal osteoarthritis Orthostatic hypotension Vascular calcification Bladder cancer stage III Toxicity to various agents Gastric cancer Paresis Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Region Gotland

Region Gotland

S:t Goransgatan 5, Visby Domkyrkofors., Visby, 621 55, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Sweden
  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Cardiac ventricular thrombosis
    Investigated Drugs:
    • Apixaban
    • Perflutren
    • Sulfur Hexafluoride
    Denmark Sweden
  • Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Amoxicillin
    • Ciprofloxacin
    • Clavulanic Acid
    Sweden
  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Sweden
  • Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Altizide
    • Cinnarizine
    • Micronised Spironolactone
    Sweden
  • Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Aliskiren
    • Enalapril Maleate
    Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!